{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:59:45Z","timestamp":1790204385141,"version":"4.1.0"},"reference-count":83,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Toxicol."],"abstract":"<jats:p>\n                    The developing brain is highly sensitive to chemical insults due to the complexity and precise timing of neurodevelopmental processes.\n                    <jats:italic>In vitro<\/jats:italic>\n                    assays targeting key neurodevelopmental events offer insights into developmental neurotoxicity (DNT) pathways and represent an important advance in alternative testing strategies. The Organisation for Economic Co-operation and Development (OECD) published initial recommendations on the design and evaluation of a DNT\n                    <jats:italic>in vitro<\/jats:italic>\n                    battery (DNT IVB) for screening chemical effects on neurodevelopment. Thus far, there has been no characterization of the regulatory application of this new testing battery due to uncertainties in assay performance, interpretation, and contextualization of bioactivity. To gain experience with evaluating assay performance and interpretation of the DNT IVB, a subset of representative, commercially available assays were used to evaluate eight natural compounds, each with established dietary background exposure and no assumed DNT risk under \u201cnormal\u201d dietary intake: EGCG, folic acid, vanillin, limonene, vitamin E, curcumin, genistein, and caffeine. Of the compounds tested, four were found to have \u201cspecific hits\u201d including EGCG, genistein, caffeine, and curcumin. Concentrations at which\n                    <jats:italic>in vitro<\/jats:italic>\n                    specific hits occurred were compared with published human plasma levels, revealing that\n                    <jats:italic>in vitro<\/jats:italic>\n                    bioactive concentrations for EGCG were within relevant human exposure levels. Conversely, for curcumin, genistein, and caffeine, any identified specific hits in the evaluated DNT IVB assays occurred at concentrations higher than reported human plasma levels indicating limited relevance for human risk assessment. Moreover, our study highlights the need for well-defined performance criteria, reproducible reference controls, a standardized approach for hit calling, benchmark response determination, and interpretation across the battery to ensure reliability and reproducibility for bolstering readiness for regulatory acceptance. Overall, while the DNT IVB provides valuable insights and opportunities for screening applications to refine chemical safety evaluation, its effective use requires strengthened guidance on assay performance, data interpretation, and integration with exposure assessment to support robust application in human health risk assessment.\n                  <\/jats:p>","DOI":"10.3389\/ftox.2026.1919390","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:10:11Z","timestamp":1790201411000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Leveraging the developmental neurotoxicity in vitro battery: lessons learned interpreting assay outputs and integrating human exposure"],"prefix":"10.3389","volume":"8","author":[{"given":"Agnes L.","family":"Karmaus","sequence":"first","affiliation":[{"name":"Syngenta Crop Protection, LLC.","place":["Greensboro, NC, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Masjosthusmann","sequence":"additional","affiliation":[{"name":"Bayer AG, CropScience Division","place":["Monheim, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Bertomeu","sequence":"additional","affiliation":[{"name":"ISK Biosciences Europe N.V.","place":["Diegem, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Ehnes","sequence":"additional","affiliation":[{"name":"BASF SE, Agricultural Solutions","place":["Limburgerhof, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Koenig","sequence":"additional","affiliation":[{"name":"Corteva Agriscience","place":["Indianapolis, IN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary S.","family":"McCarren","sequence":"additional","affiliation":[{"name":"FMC Corporation","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desir\u00e9e","family":"Mineo","sequence":"additional","affiliation":[{"name":"Syngenta Ltd., Jealott\u2019s Hill International Research Centre","place":["Bracknell, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Santos","sequence":"additional","affiliation":[{"name":"Corteva Agriscience","place":["Indianapolis, IN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike E.","family":"Schutte","sequence":"additional","affiliation":[{"name":"ADAMA Northern Europe BV.","place":["Leusden, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibek","family":"Sharma","sequence":"additional","affiliation":[{"name":"FMC Corporation","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail C.","family":"Toltin","sequence":"additional","affiliation":[{"name":"Corteva Agriscience","place":["Indianapolis, IN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Bothe","sequence":"additional","affiliation":[{"name":"Bayer AG, CropScience Division","place":["Monheim, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.14573\/altex.1712081","article-title":"Recommendation on test readiness criteria for new approach methods in toxicology: exemplified for developmental neurotoxicity","volume":"35","author":"Bal-Price","year":"2018","journal-title":"ALTEX"},{"key":"B2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2174\/1389450116666150804110049","article-title":"Is intake of flavonoid-based food supplements during pregnancy safe for the developing child? A literature review","volume":"18","author":"Barenys","year":"","journal-title":"Curr. Drug Targets"},{"key":"B3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.14573\/altex.2206031","article-title":"A human iPSC-based in vitro neural network formation assay to investigate neurodevelopmental toxicity of pesticides","volume":"40","author":"Bartmann","year":"2023","journal-title":"ALTEX"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e981","DOI":"10.1212\/NXI.0000000000000981","article-title":"Epigallocatechin gallate in relapsing-remitting multiple sclerosis: a randomized, placebo-controlled trial","volume":"8","author":"Bellmann-Strobl","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"key":"B5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.14573\/altex.2412171","article-title":"The long way from raw data to NAM-based information: overview on data layers and processing steps","volume":"42","author":"Blum","year":"2025","journal-title":"ALTEX"},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.2903\/sp.efsa.2015.EN-561","article-title":"Extensive literature search as preparatory work for the safety assessment for caffeine","volume-title":"EFSA Supporting Publication 2015:EN-561, 98 Pp. Question no EFSA-Q-2013-00419","author":"Bull","year":"2015"},{"key":"B7","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3390\/molecules30030654","article-title":"Epigallocatechin gallate (EGCG): pharmacological properties, biological activities and therapeutic potential","volume":"30","author":"Capasso","year":"2025","journal-title":"Molecules"},{"key":"B8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/toxsci\/kfac018","article-title":"Integrating data from in vitro new approach methodologies for developmental neurotoxicity","volume":"187","author":"Carstens","year":"2022","journal-title":"Toxicol. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"100360","DOI":"10.1016\/j.comtox.2025.100360","article-title":"A comparative study of biostatistical pipelines for benchmark concentration modeling of in vitro screening assays","volume":"34","author":"Carstens","year":"2025","journal-title":"Comput. Toxicol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/clpt.1990.66","article-title":"Dose-dependent pharmacokinetics of caffeine in humans: relevance as a test of quantitative liver function","volume":"47","author":"Cheng","year":"1990","journal-title":"Clin. Pharmacol. Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/humrep\/del353","article-title":"Uptake and distribution of catechins in fetal organs following in utero exposure in rats","volume":"22","author":"Chu","year":"2007","journal-title":"Hum. Reprod."},{"key":"B12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev.pharmtox.44.101802.121424","article-title":"Developmental neuropathology of environmental agents","volume":"44","author":"Costa","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1021\/jf00035a027","article-title":"Genistein, daidzein, and their.beta.-glycoside conjugates: antitumor isoflavones in soybean foods from American and Asian diets","volume":"41","author":"Coward","year":"1993","journal-title":"J. Agric. Food Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1741-4520.2012.00377.x","article-title":"Developmental neurotoxicity testing: a path forward","volume":"52","author":"Crofton","year":"2012","journal-title":"Congenit. Anom. (Kyoto)"},{"key":"B15","volume-title":"Additives in Tabacco Products - General Information\/Vanillin","year":"2012"},{"key":"B16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/s0890-6238(01)00108-3","article-title":"Placental transfer of the soy isoflavone genistein following dietary and gavage administration to sprague dawley rats","volume":"15","author":"Doerge","year":"2001","journal-title":"Reprod. Toxicol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/sim.4780100614","article-title":"Step-down multiple tests for comparing treatments with a control in unbalanced one-way layouts","volume":"10","author":"Dunnett","year":"1991","journal-title":"Stat. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2903\/j.efsa.2007.393","article-title":"Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food (AFC) related to flavouring group evaluation 22 (FGE.22): ring-Substituted phenolic substances from chemical groups 21 and 25","volume":"5","year":"2007","journal-title":"EFSA J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.2903\/j.efsa.2010.1679","article-title":"Scientific opinion on the re-evaluation of curcumin (E 100) as a food additive","volume":"8","year":"2010","journal-title":"EFSA J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.2903\/j.efsa.2015.4246","article-title":"Scientific opinion on the risk assessment for peri- and post-menopausal women taking food supplements containing isolated isoflavones","volume":"13","year":"2015","journal-title":"EFSA J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5239","DOI":"10.2903\/j.efsa.2018.5239","article-title":"Scientific opinion on the safety of green tea catechins","volume":"16","author":"Younes","year":"2018","journal-title":"EFSA J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.2903\/j.efsa.2011.2178","article-title":"Scientific opinion on flavouring group evaluation 78, revision 1 (FGE.78Rev1): consideration of aliphatic and alicyclic and aromatic hydrocarbons evaluated by JECFA (63rd meeting) structurally related to aliphatic and aromatic hydrocarbons evaluated by EFSA in FGE.25Rev2","volume":"9","year":"2011","journal-title":"EFSA J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.2903\/j.efsa.2015.4102","article-title":"Scientific opinion on the safety of caffeine","volume":"13","year":"","journal-title":"EFSA J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.2903\/j.efsa.2015.4149","article-title":"Scientific opinion on dietary reference values for vitamin E as \u03b1-tocopherol","volume":"13","year":"","journal-title":"EFSA J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e08353","DOI":"10.2903\/j.efsa.2023.8353","article-title":"Scientific opinion on the tolerable upper intake level for folate","volume":"21","year":"2023","journal-title":"EFSA J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e9814","DOI":"10.2903\/j.efsa.2025.9814","article-title":"Scientific opinion on the application of physiologically based kinetic (PBK) modelling for the quantitative in vitro to in vivo extrapolation (QIVIVE) of developmental neurotoxicity in vitro battery (DNT IVB) data for pesticide active substances","volume":"23","author":"Coja","year":"2025","journal-title":"EFSA J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/bioinformatics\/btw680","article-title":"Tcpl: the ToxCast pipeline for high-throughput screening data","volume":"33","author":"Filer","year":"2017","journal-title":"Bioinformatics"},{"key":"B30","volume-title":"Manual of Laboratory and Diagnostic Tests","author":"Fischbach","year":"2015"},{"key":"B31","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/cyto.a.24514","article-title":"Reliable identification and quantification of neural cells in microscopic images of neurospheres","volume":"101","author":"F\u00f6rster","year":"2022","journal-title":"Cytom. A"},{"key":"B32","unstructured":"Mvtnorm: Multivariate normal and t distributions\n          \n          \n            \n              Genz\n              A.\n            \n            \n              Bretz\n              F.\n            \n            \n              Miwa\n              T.\n            \n            \n              Mi\n              X.\n            \n            \n              Leisch\n              F.\n            \n            \n              Scheipl\n              F.\n            \n          \n          \n          2020"},{"key":"B33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/B978-0-08-046884-6.01525-6","article-title":"12.19 - developmental neurotoxicology","volume-title":"Comprehensive Toxicology","author":"Henck","year":"2010"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1039\/d0fo00565g","article-title":"Prospective randomized trial evaluating blood and prostate tissue concentrations of green tea polyphenols and quercetin in men with prostate cancer","volume":"11","author":"Henning","year":"2020","journal-title":"Food Funct."},{"key":"B35","doi-asserted-by":"publisher","first-page":"706","DOI":"10.14573\/altex.2310021","article-title":"Acceptance criteria for new approach methods in toxicology and human health-relevant life science research - part I","volume":"40","author":"Holzer","year":"2023","journal-title":"ALTEX"},{"key":"B36","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.yrtph.2018.03.019","article-title":"The safety of green tea and green tea extract consumption in adults - results of a systematic review","volume":"95","author":"Hu","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"B37","article-title":"Dietary reference intakes for vitamin C","volume-title":"Selenium, and Carotenoids","author":"Vitamin","year":"2000"},{"key":"B38","first-page":"909","article-title":"Evaluation of certain food additives and contaminants","volume-title":"Fifty-Seventh Report of the Joint FAO\/WHO Expert Committee on Food Additives","year":"2002"},{"key":"B39","volume-title":"Evaluation of Certain Food Additives and Contaminants: Sixty-First Report of the Joint FAO\/WHO Expert Committee on Food Additives","year":"2004"},{"key":"B40","doi-asserted-by":"publisher","first-page":"105444","DOI":"10.1016\/j.yrtph.2023.105444","article-title":"A perspective on in vitro developmental neurotoxicity test assay results: an expert panel review","volume":"143","author":"Juberg","year":"2023","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1289\/ehp.0901392","article-title":"In vitro screening of environmental chemicals for targeted testing prioritization: the ToxCast project","volume":"118","author":"Judson","year":"2010","journal-title":"Environ. Health Perspect."},{"key":"B42","doi-asserted-by":"publisher","first-page":"619","DOI":"10.14573\/altex.2210171","article-title":"The impact of biostatistics on hazard characterization using in vitro developmental neurotoxicity assays","volume":"40","author":"Ke\u00dfel","year":"2023","journal-title":"ALTEX"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1267035","DOI":"10.3389\/fnut.2023.1267035","article-title":"Non-therapeutic plasma levels in individuals utilizing curcumin supplements in daily life","volume":"10","author":"Kroon","year":"2023","journal-title":"Front. Nutr."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1002\/jssc.201600466","article-title":"Online restricted-access material combined with high-performance liquid chromatography and tandem mass spectrometry for the simultaneous determination of vanillin and its vanillic acid metabolite in human plasma","volume":"39","author":"Li","year":"2016","journal-title":"J. Sep. Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1038\/s41598-017-02384-x","article-title":"Tea-induced improvement of endothelial function in humans: no role for epigallocatechin gallate (EGCG)","volume":"7","author":"Lorenz","year":"2017","journal-title":"Sci. Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/toxsci\/kfad007","article-title":"Considering developmental neurotoxicity in vitro data for human health risk assessment using physiologically-based kinetic modeling: deltamethrin case study","volume":"192","author":"Maass","year":"2023","journal-title":"Toxicol. Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2903\/sp.efsa.2020.EN-1938","article-title":"Establishment of an a priori protocol for the implementation and interpretation of an in-vitro testing battery for the assessment of developmental neurotoxicity","volume":"17","author":"Masjosthusmann","year":"2020","journal-title":"EFSA Supporting Publication"},{"key":"B48","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1158\/1940-6207.CAPR-12-0452","article-title":"Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer","volume":"6","author":"Miller","year":"2013","journal-title":"Cancer Prev. Res. (Phila)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1039\/d0fo02485f","article-title":"Chocolate as a food matrix reduces the bioavailability of galloylated catechins from green tea in healthy women","volume":"12","author":"Mukai","year":"2021","journal-title":"Food Funct."},{"key":"B50","unstructured":"Tumeric\n          \n          \n          2025"},{"key":"B51","unstructured":"Vitamin E - Fact sheet for health professionals\n          \n          \n          2021"},{"key":"B52","first-page":"141","article-title":"The neurosphere assay as an in vitro method for developmental neurotoxicity (DNT) evaluation","volume-title":"Neuromethods","author":"Nimtz","year":"2019"},{"key":"B53","volume-title":"Toxicity Testing: Strategies to Determine Needs and Priorities","year":"1984"},{"key":"B54","volume-title":"Toxicity Testing in the 21st Century: A Vision and a Strategy","year":"2007"},{"key":"B55","volume-title":"Test No. 426: Developmental Neurotoxicity Study, OECD Guidelines for the Testing of Chemicals, Section 4","year":"2007"},{"key":"B57","article-title":"Initial recommendations on evaluation of data from the developmental neurotoxicity (DNT) in-vitro testing battery","volume-title":"OECD Series on Testing and Assessment, No. 377","year":"2023"},{"key":"B59","volume-title":"Test No. 443: Extended One-Generation Reproductive Toxicity Study, OECD Guidelines for the Testing of Chemicals, Section 4","year":""},{"key":"B60","article-title":"Principles of quantitative in vitro to in vivo extrapolation (QIVIVE) - as example applied to the DNT IVB, OECD series on testing and assessment, no. 411, OECD environment","year":"","journal-title":"Health Saf."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1111\/j.2042-7158.2011.01326.x","article-title":"Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics","volume":"63","author":"Perera","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.3390\/ijms20153630","article-title":"Function of green tea catechins in the brain: epigallocatechin gallate and its metabolites","volume":"20","author":"Pervin","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B63","unstructured":"R: a language and environment for statistical computing\n          \n          \n          2022"},{"key":"B64","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00394-002-0365-3","article-title":"Tocopherol metabolites 2, 5, 7, 8-tetramethyl-2-(2'-carboxyethyl)-6-hydroxychroman (alpha-CEHC) and 2, 7, 8-trimethyl-2-(2'-carboxyethyl)-6-hydroxychroman (gamma-CEHC) in human serum after a single dose of natural vitamin E","volume":"41","author":"Radosavac","year":"2002","journal-title":"Eur. J. Nutr."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e0146021","DOI":"10.1371\/journal.pone.0146021","article-title":"Dose-response analysis using R","volume":"10","author":"Ritz","year":"2015","journal-title":"PLoS One"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneng.2011.00001","article-title":"In vitro assessment of developmental neurotoxicity: use of microelectrode arrays to measure functional changes in neuronal network ontogeny","volume":"4","author":"Robinette","year":"2011","journal-title":"Front. Neuroeng"},{"key":"B67","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3390\/nu13020344","article-title":"The consumption of caffeine-containing products to enhance sports performance: an application of an extended model of the theory of planned behavior","volume":"13","author":"Samoggia","year":"2021","journal-title":"Nutrients"},{"key":"B68","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.2147\/IJN.S514247","article-title":"From citrus to clinic: limonene's journey through preclinical research, clinical trials, and formulation innovations","volume":"20","author":"Sanshita","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"B69","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/mnfr.201300724","article-title":"The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes","volume":"58","author":"Schiborr","year":"2014","journal-title":"Mol. Nutr. Food Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s00204-016-1852-2","article-title":"Omnisphero: a high-content image analysis (HCA) approach for phenotypic developmental neurotoxicity (DNT) screenings of organoid neurosphere cultures in vitro","volume":"91","author":"Schmuck","year":"2017","journal-title":"Arch. Toxicol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e0193074","DOI":"10.1371\/journal.pone.0193074","article-title":"Population nutrikinetics of green tea extract","volume":"13","author":"Scholl","year":"2018","journal-title":"PLoS One"},{"key":"B72","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/ajcn\/76.3.588","article-title":"Pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage","volume":"76","author":"Shelnutt","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"key":"B73","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41538-025-00396-w","article-title":"Biological, dietetic and pharmacological properties of vitamin B9","volume":"9","author":"Siatka","year":"2025","journal-title":"NPJ Sci. Food"},{"key":"B74","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/NT.0000000000000412","article-title":"Vanilla: potential health benefits","volume":"55","author":"Singletary","year":"2020","journal-title":"Nutr. Today"},{"key":"B75","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/toxsci\/kfj077","article-title":"Kinetics of genistein and its conjugated metabolites in pregnant sprague-dawley rats following single and repeated genistein administration","volume":"90","author":"Soucy","year":"2006","journal-title":"Toxicol. Sci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/carcin\/19.10.1771","article-title":"Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue","volume":"19","author":"Suganuma","year":"1998","journal-title":"Carcinogenesis"},{"key":"B77","first-page":"259","article-title":"D-Limonene: safety and clinical applications","volume":"12","author":"Sun","year":"2007","journal-title":"Altern. Med. Rev."},{"key":"B78","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3390\/biochem4040017","article-title":"Biotechnological advances in vanillin production: from natural vanilla to metabolic engineering platforms","volume":"4","author":"Tazon","year":"2024","journal-title":"Biochem."},{"key":"B79","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1177\/147323000303100205","article-title":"A single ascending dose study of epigallocatechin gallate in healthy volunteers","volume":"31","author":"Ullmann","year":"2003","journal-title":"J. Int. Med. Res."},{"key":"B80","article-title":"OPPTS 870.6300: developmental neurotoxicity study","year":"1998","journal-title":"Health Eff. Test. Guidel."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/ejcn.2014.108","article-title":"Large inter-individual variation in isoflavone plasma concentration limits use of isoflavone intake data for risk assessment","volume":"68","author":"van der Velpen","year":"2014","journal-title":"Eur. J. Clin. Nutr."},{"key":"B82","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s002800050793","article-title":"Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer research campaign phase I\/II clinical trials committee","volume":"42","author":"Vigushin","year":"1998","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3109\/15563650.2016.1146740","article-title":"Pharmacokinetic analysis and comparison of caffeine administered rapidly or slowly in coffee chilled or hot versus chilled energy drink in healthy young adults","volume":"54","author":"White","year":"2016","journal-title":"Clin. Toxicol. (Phila)."},{"key":"B84","doi-asserted-by":"publisher","first-page":"500","DOI":"10.17772\/gp\/1760","article-title":"Comparison of maternal and fetal blood levels of caffeine and its metabolite. A pilot study","volume":"85","author":"Wierzejska","year":"2014","journal-title":"Ginekol. Pol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.toxrep.2018.11.002","article-title":"The clinical toxicology of caffeine: a review and case study","volume":"5","author":"Willson","year":"2018","journal-title":"Toxicol. Rep."},{"key":"B86","first-page":"793","article-title":"Measurement of serum vitamin E isomers in fullterm and preterm infants","volume":"24","author":"Wu","year":"2001","journal-title":"Chang. Gung Med. J."},{"key":"B87","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.biopsych.2023.01.007","article-title":"Environmental toxicants and the developing brain","volume":"93","author":"Wylie","year":"2023","journal-title":"Biol. Psychiatry"}],"container-title":["Frontiers in Toxicology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftox.2026.1919390\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:10:15Z","timestamp":1790201415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftox.2026.1919390\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":83,"alternative-id":["10.3389\/ftox.2026.1919390"],"URL":"https:\/\/doi.org\/10.3389\/ftox.2026.1919390","relation":{},"ISSN":["2673-3080"],"issn-type":[{"value":"2673-3080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"article-number":"1919390"}}